Abstract
Recently, chloroperoxidase (CPO)‐mediated enzyme dynamic therapy (EDT) by mimicking the antipathogen function of neutrophils via generating highly active signet oxygen ( 1 O 2 ) has attracted great interest in biomedical applications. However, the therapeutic efficiency of EDT is largely restricted by the low CPO delivery efficiency and insufficient hydrogen peroxide (H 2 O 2 ) supply. In the present work, a neutrophil‐mimicking nanozyme of MGBC with high CPO delivery efficiency, H 2 O 2 self‐supply, and enzyme‐cascade catalytic properties is designed for high‐efficient treatment of methicillin‐resistant Staphylococcus aureus ( MRSA ) infections. In the infection microenvironment, MGBC can effectively catalyze glucose to self‐supply substantial H 2 O 2 , which enables long‐lasting 1 O 2 generation via the CPO‐mediated catalytic reaction. At the meantime, MGBC can also catalyze H 2 O 2 to sustainably release NO for gas therapy (GT), which synergistically strengthens the therapeutic effect of EDT. As a result, MGBC displayed effective MRSA ‐killing and MSRA biofilms‐eradicating properties, and high efficiency in treating both MRSA infected full‐thickness excision wounds and subcutaneous MRSA infection by exerting the synergistic bimodal EDT/GT therapeutic effects. In‐depth mechanism study revealed that the synergistic EDT/GT antibacterial effects of MGBC can attenuate the drug resistance and toxicity of MRSA by significantly downregulating quorum sensing, multidrug efflux, virulence, and biofilm formation‐related genes.
Funding Information
  • National Natural Science Foundation of China (31900953)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515012148)

This publication has 59 references indexed in Scilit: